<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: RevBits announces issuance of two U.S. patents covering next generation email security for MS Outlook users 	</title>
	<atom:link href="https://www.newpharmaitaly.it/revbits-announces-issuance-of-two-u-s-patents-covering-next-generation-email-security-for-ms-outlook-users/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/revbits-announces-issuance-of-two-u-s-patents-covering-next-generation-email-security-for-ms-outlook-users/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Mon, 13 Jul 2020 11:01:13 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.1</generator>
</channel>
</rss>
